Pulse最新文献

{"title":"Renal Sympathetic Denervation in Patients with Resistant Hypertension: A Feasibility Study.","authors":"Kazuomi Kario,&nbsp;Jose Ramon Rumoroso,&nbsp;Yukie Okawara,&nbsp;Armando Pérez de Prado,&nbsp;Eulogio Garcia Fernandez,&nbsp;Hideaki Kagitani,&nbsp;Francisco Javier Goicolea Gómez,&nbsp;Oriol Rodríguez Leor,&nbsp;Goran Stankovic","doi":"10.1159/000490620","DOIUrl":"https://doi.org/10.1159/000490620","url":null,"abstract":"<p><strong>Background/aims: </strong>We assessed the feasibility of renal sympathetic denervation (RDN) treatment in patients with resistant hypertension using the Iberis® RDN system. This study was a prospective, multicenter, single-arm feasibility registry.</p><p><strong>Methods: </strong>We collected data from patients who underwent RDN treatment using the Iberis system. From November 2014 to February 2016, 16 patients from 6 centers in Europe were enrolled in this registry.</p><p><strong>Results: </strong>Consistent reductions in the 24-h systolic blood pressure (SBP) and diastolic blood pressure were obtained. At any follow-up point, more than 70% of the patients were responders. The change in the 24-h SBP at 1 month was strongly correlated with that at 12 months.</p><p><strong>Conclusion: </strong>The Iberis system is safe and effective in patients for the treatment of resistant hypertension. Furthermore, our results suggest that we can estimate the effect of RDN in the long term at the 1-month follow-up point using the 24-h SBP.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 3-4","pages":"137-143"},"PeriodicalIF":2.2,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000490620","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37204982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Assessment of Cutoffs for the Cardio-Ankle Vascular Index and Brachial-Ankle Pulse Wave Velocity in a Nationwide Registry: A Cardiovascular Prognostic Coupling Study.","authors":"Tomoyuki Kabutoya,&nbsp;Kazuomi Kario","doi":"10.1159/000489604","DOIUrl":"https://doi.org/10.1159/000489604","url":null,"abstract":"<p><p>Pulse wave velocity (PWV) and cardio-ankle vascular index (CAVI) are measurements of arterial stiffness and are widely used as indices of arteriosclerosis. In Japan, brachial-ankle PWV (baPWV) is generally used to measure PWV, and while the reference value for this parameter is specified in Japanese guidelines for the noninvasive vascular function test, the CAVI reference value has not been standardized. We measured CAVI in 4,545 patients with at least one cardiovascular risk factor, and baPWV in 1,737 of these 4,545 patients on the same day as a part of an ongoing nationwide registry. The association between CAVI and baPWV was positive and significant (<i>r</i> = 0.50, <i>p</i> < 0.001). The CAVI corresponding to baPWV 14 m/s derived from the regression line was 8.303 and the CAVI corresponding to baPWV 18 m/s was 9.059. The percentages of patients with low risk (CAVI < 8.303), medium risk (CAVI 8.303-9.058) and high risk (CAVI ≥9.059) were 35.0, 23.0, and 42.0% in 4,545 patients who underwent CAVI, respectively. The percentages of patients with baPWV < 14 m/s, baPWV 14-18 m/s and baPWV ≥18 m/s were 22.9, 47.3, and 29.8% in 1,737 patients who underwent both baPWV and CAVI, respectively. The average baPWV in low-risk patients (CAVI < 8.303, <i>n</i> = 642) was 14.97 ± 2.91 m/s, that in medium-risk patients (CAVI 8.303-9.058, <i>n</i> = 408) was 16.12 ± 2.80 m/s, and that in high-risk patients (CAVI ≥9.059, <i>n</i> = 687) was 18.40 ± 3.51 m/s. CAVI < 8.303 corresponded to a baPWV cutoff of 14 m/s, and CAVI ≥9.059 corresponded to a baPWV cutoff of 18 m/s. The results of this ongoing prospective study are expected to confirm the association between the CAVI reference value and cardiovascular events.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 3-4","pages":"131-136"},"PeriodicalIF":2.2,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000489604","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37204981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Urinary Metabolites and Their Link with Premature Arterial Stiffness in Black Boys: The ASOS Study.","authors":"Dalene Erasmus,&nbsp;Carina M C Mels,&nbsp;Roan Louw,&nbsp;J Zander Lindeque,&nbsp;Ruan Kruger","doi":"10.1159/000492155","DOIUrl":"https://doi.org/10.1159/000492155","url":null,"abstract":"<p><strong>Background and aims: </strong>Black boys (6-8 years of age) were shown to have higher pulse wave velocity with potential early vascular compromise. We aimed to compare predefined urinary metabolites in black and white boys to explore associations of pulse wave velocity with these metabolites.</p><p><strong>Methods and results: </strong>We included 40 white and 40 black apparently healthy boys between the ages of 6 and 8 years. Femoral pulse wave velocity was measured along with various metabolites using liquid chromatography tandem mass spectrometry (LC-MS/MS) and gas chromatography-time of flight-mass spectrometry (GC-TOF-MS) methods. Pulse wave velocity and diastolic blood pressure were higher in the black compared to the white boys (both <i>p</i> ≤ 0.002). Isovalerylcarnitine was lower and 1-metylhistidine tended to be lower (<i>p</i> = 0.002 and <i>p</i> = 0.073, respectively), whereas L-proline levels tended to be higher (<i>p</i> = 0.079) in the black compared to the white boys. In single, partial, and multiple regression analyses, pulse wave velocity correlated inversely with β-alanine (β = -0.414; <i>p</i> = 0.008) and 1-methylhistidine (β = -0.347; <i>p</i> = 0.032) and positively with L-proline (β = 0.420; <i>p</i> = 0.008), threonic acid (β = 0.977; <i>p</i> = 0.033), and malonic acid (β = 0.348; <i>p</i> = 0.030) in black boys only.</p><p><strong>Conclusion: </strong>Our study is the first to discover the associations of pulse wave velocity with β-alanine, 1-methylhistidine, and L-proline in children from South Africa, which may suggest potential early compromise in cardiac protective metabolic pathways in black boys as young as 6 years of age.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 3-4","pages":"144-153"},"PeriodicalIF":2.2,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000492155","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37204937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cuff-Based Oscillometric Measurements of Central Hemodynamics: Factors Influencing Central Augmentation Pressure in Normotensive Japanese Individuals.","authors":"Masakazu Obayashi,&nbsp;Shigeki Kobayashi,&nbsp;Michiaki Kohno,&nbsp;Tomoko Nakashima,&nbsp;Masafumi Yano","doi":"10.1159/000496151","DOIUrl":"https://doi.org/10.1159/000496151","url":null,"abstract":"<p><strong>Background: </strong>Recently, new devices using oscillometric cuff have been developed to derive central blood pressure (BP) waveform from brachial BP waveform. Late systolic pressure augmentation of central BP waveform is a marker of central hemodynamics. Mobil-O-Graph, a cuff-based oscillometric device, can assess central augmentation pressure (AP) together with central BP. Central AP measurement using the Mobil-O-Graph in the European population was reported to be associated with age and sex. However, factors influencing central AP in the Asian population have not been shown.</p><p><strong>Objectives and methods: </strong>We enrolled 110 normotensive volunteers (50 men; age range, 21‒76 years). Central BP and AP were measured using the Mobil-O-Graph on the left arm with the subjects in the seated position after resting for at least 5 min. We compared central hemodynamics between the sexes. We investigated factors influencing central AP in uni- and multivariate linear regression analyses and age-related change in central AP using the Mobil-O-Graph in healthy Japanese individuals.</p><p><strong>Results: </strong>Central AP were lower in men than in women (5.5 ± 2.8 vs. 11.0 ± 4.7 mm Hg, <i>p</i> < 0.001). The central AP in the total cohort was positively correlated with age (<i>r</i> = 0.325, <i>p</i> < 0.001) and inversely correlated with height (<i>r</i> = -0.601, <i>p</i> < 0.001) in the Pearson correlations. In multivariate regression analysis, the parameters influencing central AP (<i>R</i>>sup<2>/sup< = 0.467) were age (β = 0.097, <i>p</i> < 0.001), sex (β = -2.890, <i>p</i> = 0.010), and height (β = -0.153, <i>p</i> = 0.031). The central AP (10.0 ± 4.8 mm Hg) in the ≥50-year-old group significantly increased compared with those in the 20- to 39-year-old group (6.7 ± 4.2 mm Hg, <i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Age, sex, and height influenced central AP, as assessed using the Mobil-O-Graph. Age-related increase in central AP was observed in normotensive Japanese individuals. Brachial cuff-based waveform recordings using the Mobil-O-Graph are feasible for the estimation of central AP in the Asian population.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 3-4","pages":"161-168"},"PeriodicalIF":2.2,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000496151","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37205410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Hemoglobin and Blood Pressure in a Chinese Community-Dwelling Population.","authors":"Yan Xuan,&nbsp;Junli Zuo,&nbsp;Shuping Zheng,&nbsp;Jinbao Ji,&nbsp;Yi Qian","doi":"10.1159/000494735","DOIUrl":"https://doi.org/10.1159/000494735","url":null,"abstract":"<p><p>This study investigated the relationship between hemoglobin (Hb) level and blood pressure in a Chinese community-dwelling population with normal glucose metabolism. Hb, fasting plasma glucose, glycated Hb A1c, hepatic and renal function, lipid, electrolytes, and anthropometric parameters were measured. Hb level was found to be positively correlated with systolic (SBP; <i>r</i> = 0.075, <i>p</i> < 0.001) and diastolic (DBP; <i>r</i> = 0.272, <i>p</i> < 0.001) blood pressure in the cohort. The relationship was not affected by age, BMI, serum creatinine (Cr), and low-density lipoprotein (LDL) in both males and females. Multivariate stepwise regression showed that age (β = 0.556, <i>p</i> < 0.001), BMI (β = 1.107, < 0.001), Hb (β = 0.082, <i>p</i> < 0.001), Cr (β = -0.032, <i>p</i> < 0.001), and LDL (β = 1.023, <i>p</i> < 0.001) were independent factors for SBP, and Hb (β = 0.168, <i>p</i> < 0.001), BMI (β = 0.519, <i>p</i> = 0.001), and LDL (β = 0.331, <i>p</i> < 0.001) for DBP. Hb level is positively associated with both SBP and DBP in a Chinese community-dwelling population with normal glucose metabolism.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 3-4","pages":"154-160"},"PeriodicalIF":2.2,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000494735","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37205409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Simultaneous Detection and Differentiation of Chikungunya Virus and Dengue Virus in Blood at Clinical Presentation by Real Time RT-PCR","authors":"MM Rahman, R Rahim, AH Rasel, AS Murad","doi":"10.3329/pulse.v10i1.38605","DOIUrl":"https://doi.org/10.3329/pulse.v10i1.38605","url":null,"abstract":"Background: Chikungunya viral infection in Bangladesh has marked 2017 summer with unprecedented magnitude for the first time. Chikungunya virus (CHIKV) and Dengue virus (DENV) are arboviruses that share the same Aedes mosquito vectors and thus overlap in their endemic areas.These two viruses cause similar clinical presentations, especially in the initial stages of infection. Because the outcomes and management strategies for these two viruses are different, early and accurate diagnosis is imperative. Early diagnosis is also important for surveillance and outbreak control. Objective: As virus isolation is not undergoing in the country and antigen based commercial detection assay is not available for CHIKV we used one step real time reverse transcriptase polymerase chain reaction (RT-PCR) method to detect and discriminate CHIKV and DENV in blood during suspicious clinical symptoms. Results: By this RT-PCR method we have detected 603 cases of CHIKV and 233 cases of DENV and thus facilitated rapid diagnosis and clinical management in the recent CHIKV outbreaks in the country. Conclusion: This is the first report about molecular detection and differentiation of CHIKV and DENV at time of clinical presentation and further show evidence of simultaneous outbreaks of both the viral infections in the country. Pulse Vol.10 January-December 2017 p.6-11","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"122 ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2018-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138505779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High-Intensity Statin Therapy Is \"Too Much,\" Thus Not Indicated for Very Elderly Patients.","authors":"Ok Sang Lee,&nbsp;Jinlong Zhang,&nbsp;Sun-Hoi Jung,&nbsp;Hyang-Sook Kim,&nbsp;Myung-Koo Lee,&nbsp;Hae-Young Lee","doi":"10.1159/000485659","DOIUrl":"https://doi.org/10.1159/000485659","url":null,"abstract":"<p><strong>Purpose: </strong>Although moderate- to high-intensity statin therapy is increasingly recommended in cardiovascular disease patients, the efficacy and safety in elderly patients have not been proven clearly. Here, we compare the effect of various-intensity statins between elderly and very elderly patients.</p><p><strong>Methods: </strong>43,870 patients over 65 years old who were treated with statins were screened using electronic medical record data.</p><p><strong>Results: </strong>We evaluated 451 patients in the elderly group aged 65-74 years and 159 patients in the very elderly group over 75 years old. Baseline cholesterol profiles were similar between the 2 groups, but the 10-year atherosclerotic cardiovascular disease (ASCVD) risk was significantly higher in the very elderly (20.9 ± 11.5$ vs. 37.2 ± 13.6$, <i>p <</i> 0.001). The reduction rate of low-density lipoprotein (LDL) (-40.2 ± 21.3$ vs. -39.3 ± 21.0$, <i>p</i> = 0.634) and the ratio of target LDL attainment (74.2 vs. 79.2$, <i>p</i> = 0.252) were similar between the 2 groups. Low-intensity statins showed comparable LDL cholesterol reduction with moderate-intensity statins both in the elderly and the very elderly groups. The 10-year ASCVD risk reduction was similar between the 2 groups (-3.5 ± 4.9$ vs. -3.0 ± 8.4$, <i>p</i> = 0.480), but in the very elderly group, no different ASCVD reduction rate was shown in low- to high-intensity statins (<i>p</i> = 0.784). Only the elderly group showed a significant correlation (<i>r</i> = 0.112, <i>p</i> = 0.017) with LDL reduction and 10-year ASCVD risk. Interestingly, the incidence of adverse drug reaction (ADR) was higher in the very elderly group (4.4$) than in the elderly group (2.7$) and was more frequent in high-intensity statin therapy.</p><p><strong>Conclusion: </strong>The efficacy of statins in LDL reduction was similar between the elderly and very elderly population. However, the benefit of moderate- to high-intensity statins is limited considering potential ADR. Therefore, the stepwise intensification of statin therapy might be necessary for the very elderly in spite of the higher cardiovascular risk.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 1-2","pages":"19-31"},"PeriodicalIF":2.2,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000485659","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36555481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials.","authors":"Yi Chen,&nbsp;Lei Lei,&nbsp;Ji-Guang Wang","doi":"10.1159/000489855","DOIUrl":"https://doi.org/10.1159/000489855","url":null,"abstract":"<p><p>In the present review, we summarized the blood pressure (BP) measurement protocols of contemporary outcome trials in hypertension. In all these trials, clinic BP was used for the diagnosis and therapeutic monitoring of hypertension. In most trials, BP was measured in the sitting position with mercury sphygmomanometers or automated electronic BP monitors by trained observers. BP readings were taken on each occasion at least twice with a 30-to-60-s interval after 5 min of rest. Details regarding the arm side, cuff size, and the timing of BP measurement were infrequently reported. If clinic BP continues being used in future hypertension trials, the measurement should strictly follow current guidelines. The observers must be trained and experienced, and the device should be validated by automated electronic BP monitors. On each occasion, BP readings should be taken 2-3 times. The time interval between successive measurements has to be 30-60 s, and the resting period before the measurement should be at least 5 min in the supine or seated position and 1-3 min standing. BP should usually be measured in the seated position. The higher arm side and an appropriate size cuff should be chosen and noted. BP should be measured at defined trough hours. Automated office BP measurement has recently been used and seems to have less white-coat effect. The out-of-office BP measurement, either ambulatory or home BP monitoring, was only used in a subset of study participants of few hypertension trials. Future trials should consider these novel office or out-of-office BP measurements in guiding the therapy and preventing cardiovascular events.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 1-2","pages":"112-123"},"PeriodicalIF":2.2,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000489855","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36555484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Central Blood Pressure in an Asian Population: Comparison between Brachial Oscillometry and Radial Tonometry Methods.","authors":"Satoshi Hoshide,&nbsp;Takahiro Komori,&nbsp;Yukiyo Ogata,&nbsp;Kazuo Eguchi,&nbsp;Kazuomi Kario","doi":"10.1159/000484442","DOIUrl":"https://doi.org/10.1159/000484442","url":null,"abstract":"<p><strong>Background: </strong>New devices have recently been developed using various features of the waveform derived from a brachial cuff for noninvasive estimation of central systolic blood pressure (SBP). Central SBP estimated from brachial oscillometry has never been compared with that estimated from radial tonometry in a Japanese population.</p><p><strong>Subjects and methods: </strong>We recruited 155 Japanese volunteers (mean age 58 ± 16 years, range 18-99 years; 66.5$ women) and estimated their central SBP using brachial oscillometry (Mobil-O-Graph) or radial tonometry (SphygmoCor).</p><p><strong>Results: </strong>The mean (standard deviation) peripheral SBP and central SBP measured with brachial oscillometry was 128 ± 18 mm Hg and 118 ± 16 mm Hg, respectively, while the central SBP estimated using radial tonometry was 119 ± 18 mm Hg. The mean (standard deviation) difference in estimated central SBP between brachial oscillometry and radial tonometry was 0.36 ± 5.9 mm Hg, and the central SBPs estimated using these devices were strongly correlated (<i>r</i> = 0.946, intraclass correlation coefficient = 0.940, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Central SBP estimated using brachial oscillometry was similar to that estimated from radial tonometry in a Japanese population.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 1-2","pages":"98-102"},"PeriodicalIF":2.2,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000484442","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36555482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Obstructive Sleep Apnea Is Closely Related to Cardiovascular Risk Factors, but Not to Clinical Recurrence of Atrial Fibrillation after Catheter Ablation: An Analysis of Atrial Fibrillation Patients.","authors":"Chan Joo Lee,&nbsp;Tae-Hoon Kim,&nbsp;Sungha Park,&nbsp;Hui-Nam Pak","doi":"10.1159/000489854","DOIUrl":"https://doi.org/10.1159/000489854","url":null,"abstract":"<p><strong>Background: </strong>Obstructive sleep apnea (OSA) is a well-known predictor of atrial fibrillation (AF). However, OSA usually accompanies other risk factors of AF. We tried to investigate whether OSA is related to AF recurrence after catheter ablation.</p><p><strong>Methods: </strong>A total of 378 patients (mean age 59.9 ± 10.7 years, 72.5$ male) who underwent catheter ablation of AF were enrolled and underwent overnight ambulatory polysomnography before the ablation procedure. These patients were examined once every 3 months at the outpatient clinic to determine AF recurrence.</p><p><strong>Results: </strong>Based on the apnea-hypopnea index (AHI), we divided the study subjects into 3 groups defined as mild (AHI < 10), moderate (10 <AHI < 30), or severe (AHI > 30) OSA. Patients with severe OSA had a higher prevalence of hypertension, diabetes mellitus, and coronary artery disease (CAD). However, AF recurrence was not different between the three groups. The Kaplan-Meier analysis also showed no significant difference in AF recurrence according to the degree of severity of OSA. Multivariate logistic regression analysis revealed that OSA might be a predictor of CAD; however, Cox regression analysis showed that only early recurrence is closely related to AF recurrence after catheter ablation, rather than the severity of OSA.</p><p><strong>Conclusion: </strong>This study shows that the severity of OSA is not associated with the recurrence of AF after catheter ablation in Korean patients. Treatment of OSA for the sole indication of lowering AF recurrence may need to be reconsidered.</p>","PeriodicalId":29774,"journal":{"name":"Pulse","volume":"6 1-2","pages":"103-111"},"PeriodicalIF":2.2,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000489854","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36555483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}